|
Volumn 97, Issue 3, 2002, Pages 377-378
|
Should we start population screening for prostate cancer? Randomised trials are still needed
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER DIAGNOSIS;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER SCREENING;
DIAGNOSTIC ACCURACY;
ECONOMIC ASPECT;
EDITORIAL;
HUMAN;
MALE;
MASS SCREENING;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
QUALITY OF LIFE;
RELIABILITY;
UNITED KINGDOM;
UNITED STATES;
VALIDATION PROCESS;
CLINICAL TRIALS;
HUMANS;
MALE;
MASS SCREENING;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TIME FACTORS;
|
EID: 0037137874
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/ijc.1621 Document Type: Editorial |
Times cited : (14)
|
References (19)
|